These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26170941)

  • 1. Cystatin C is a moderate predictor of acute kidney injury in the early stage of traumatic hemorrhagic shock.
    Chen S; Shi JS; Yibulayin X; Wu TS; Yang XW; Zhang J; Baiheti P
    Exp Ther Med; 2015 Jul; 10(1):237-240. PubMed ID: 26170941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.
    Zappitelli M; Greenberg JH; Coca SG; Krawczeski CD; Li S; Thiessen-Philbrook HR; Bennett MR; Devarajan P; Parikh CR;
    JAMA Pediatr; 2015 Jun; 169(6):583-91. PubMed ID: 25844892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides.
    Lau L; Al-Ismaili Z; Harel-Sterling M; Pizzi M; Caldwell JS; Piccioni M; Lands LC; Mottes T; Devarajan P; Goldstein SL; Bennett MR; Zappitelli M
    Pediatr Nephrol; 2017 Jan; 32(1):163-171. PubMed ID: 27743042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C as an early marker of acute kidney injury and predictor of mortality in the intensive care unit after acute myocardial infarction.
    Fouad M; Boraie M
    Arab J Nephrol Transplant; 2013 Jan; 6(1):21-6. PubMed ID: 23282229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C and serum creatinine in estimating acute kidney injury of shock patients.
    Li Q; Fang JY; Wang WP; Liu JH; Wang KK
    World J Emerg Med; 2010; 1(3):185-9. PubMed ID: 25214965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?
    Lagos-Arevalo P; Palijan A; Vertullo L; Devarajan P; Bennett MR; Sabbisetti V; Bonventre JV; Ma Q; Gottesman RD; Zappitelli M
    Pediatr Nephrol; 2015 Apr; 30(4):665-76. PubMed ID: 25475610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Thyroid Function, Inflammation, and Obesity on Risk Prediction of Acute Kidney Injury by Cystatin C in the Emergency Department.
    Schanz M; Pannes D; Dippon J; Wasser C; Alscher MD; Kimmel M
    Kidney Blood Press Res; 2016; 41(5):604-613. PubMed ID: 27578194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury.
    Belcher JM; Sanyal AJ; Garcia-Tsao G; Ansari N; Coca SG; Shlipak MG; Parikh CR
    Int J Nephrol; 2014; 2014():708585. PubMed ID: 24757564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtle change of cystatin C, with or without acute kidney injury, associated with increased mortality in the intensive care unit.
    Kwon SH; Hyun J; Jeon JS; Noh H; Han DC
    J Crit Care; 2011 Dec; 26(6):566-71. PubMed ID: 21419594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C could be a replacement to serum creatinine for diagnosing and monitoring kidney function in children.
    Narvaez-Sanchez R; Gonzalez L; Salamanca A; Silva M; Rios D; Arevalo S; Gastelbondo R; Sanchez J
    Clin Biochem; 2008 May; 41(7-8):498-503. PubMed ID: 18280806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis.
    Matsuki M; Tanaka T; Maehana T; Kyoda Y; Ichihara K; Hashimoto K; Yanase M; Matsukawa M; Adachi H; Takahashi S; Masumori N
    Clin Exp Nephrol; 2017 Oct; 21(5):852-857. PubMed ID: 28258496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impacts of thyroid function on the diagnostic accuracy of cystatin C to detect acute kidney injury in ICU patients: a prospective, observational study.
    Wang F; Pan W; Wang H; Zhou Y; Wang S; Pan S
    Crit Care; 2014 Jan; 18(1):R9. PubMed ID: 24405645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis.
    Zhang Z; Lu B; Sheng X; Jin N
    Am J Kidney Dis; 2011 Sep; 58(3):356-65. PubMed ID: 21601330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C: an improved estimator of glomerular filtration rate?
    Laterza OF; Price CP; Scott MG
    Clin Chem; 2002 May; 48(5):699-707. PubMed ID: 11978596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age.
    Lankisch P; Wessalowski R; Maisonneuve P; Haghgu M; Hermsen D; Kramm CM
    Pediatr Blood Cancer; 2006 Jun; 46(7):767-72. PubMed ID: 16550534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of renal function in renal transplant patients using cystatin C. A comparison to other renal function markers and estimates.
    Risch L; Blumberg A; Huber AR
    Ren Fail; 2001; 23(3-4):439-48. PubMed ID: 11499559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cystatin-C as a marker of acute kidney injury in the newborn after perinatal hypoxia/asphyxia.
    Treiber M; Gorenjak M; Pecovnik Balon B
    Ther Apher Dial; 2014 Feb; 18(1):57-67. PubMed ID: 24499085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of novel biomarker NGAL in early diagnosis of acute renal injury.
    Zhang J; Han J; Liu J; Liang B; Wang X; Wang C
    Exp Ther Med; 2017 Nov; 14(5):5017-5021. PubMed ID: 29201207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.